{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T18:10:03Z","timestamp":1778695803082,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009399","name":"Peking University Third Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81672410"],"award-info":[{"award-number":["81672410"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007937","name":"Peking University","doi-asserted-by":"publisher","award":["Y57405-32"],"award-info":[{"award-number":["Y57405-32"]}],"id":[{"id":"10.13039\/501100007937","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.bbagrm.2022.194829","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T18:35:46Z","timestamp":1653935746000},"page":"194829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer"],"prefix":"10.1016","volume":"1865","author":[{"given":"Shiyu","family":"Xiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyu","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueli","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagrm.2022.194829_bb0005","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0010","doi-asserted-by":"crossref","first-page":"776","DOI":"10.3389\/fonc.2020.00776","article-title":"Proline metabolism in tumor growth and metastatic progression","volume":"10","author":"D'Aniello","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3892\/ijo.2017.4000","article-title":"Gastric cancer: Metabolic and metabolomics perspectives (review)","volume":"51","author":"Xiao","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0020","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1016\/j.bmcl.2019.07.047","article-title":"A fragment-like approach to PYCR1 inhibition","volume":"29","author":"Milne","year":"2019","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0025","doi-asserted-by":"crossref","first-page":"18316","DOI":"10.1074\/jbc.RA120.016106","article-title":"In crystallo screening for proline analog inhibitors of the proline cycle enzyme PYCR1","volume":"295","author":"Christensen","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0030","doi-asserted-by":"crossref","first-page":"937","DOI":"10.21037\/atm-19-4402","article-title":"Pyrroline-5-carboxylate reductase 1 (PYCR1) upregulation contributes to gastric cancer progression and indicates poor survival outcome","volume":"8","author":"Xiao","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0035","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0040","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0045","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/nm.3850","article-title":"Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes","volume":"21","author":"Cristescu","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0050","doi-asserted-by":"crossref","first-page":"8983","DOI":"10.1073\/pnas.1203244109","article-title":"Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0055","doi-asserted-by":"crossref","first-page":"17206","DOI":"10.1038\/srep17206","article-title":"Proline biosynthesis augments tumor cell growth and aerobic glycolysis: involvement of pyridine nucleotides","volume":"5","author":"Liu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0060","doi-asserted-by":"crossref","first-page":"5962","DOI":"10.3748\/wjg.14.5962","article-title":"MYC and gastric adenocarcinoma carcinogenesis","volume":"14","author":"Calcagno","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0065","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.3390\/cancers6031441","article-title":"The role of PI3K\/Akt\/mTOR signaling in gastric carcinoma","volume":"6","author":"Matsuoka","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0070","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nrgastro.2017.53","article-title":"How to stomach an epigenetic insult: the gastric cancer epigenome","volume":"14","author":"Padmanabhan","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.3389\/fgene.2015.00287","article-title":"Design, measurement and processing of region-specific DNA methylation assays: the mass spectrometry-based method EpiTYPER","volume":"6","author":"Suchiman","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0085","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0090","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","article-title":"Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil","volume":"145","author":"Lei","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0095","first-page":"6735","article-title":"Human gastric carcinogenesis: a multistep and multifactorial process\u2013first American Cancer Society award lecture on cancer epidemiology and prevention","volume":"52","author":"Correa","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0100","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/emboj.2010.318","article-title":"Distinct roles of GCN5\/PCAF-mediated H3K9ac and CBP\/p300-mediated H3K18\/27ac in nuclear receptor transactivation","volume":"30","author":"Jin","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41420-020-00341-8","article-title":"The janus-like role of proline metabolism in cancer","volume":"6","author":"Burke","year":"2020","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0110","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1007\/s00726-021-02999-5","article-title":"Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target","volume":"53","author":"Bogner","year":"2021","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/ijc.28940","article-title":"Personalised cancer medicine","volume":"137","author":"Jackson","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0120","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/carcin\/bgx022","article-title":"Human mitochondrial pyrroline-5-carboxylate reductase 1 promotes invasiveness and impacts survival in breast cancers","volume":"38","author":"Ding","year":"2017","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0125","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/bjc.2017.387","article-title":"MYC regulation of glutamine-proline regulatory axis is key in luminal B breast cancer","volume":"118","author":"Craze","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0130","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.3390\/cancers13133159","article-title":"Tumor classification should be based on biology and not consensus: re-defining tumors based on biology may accelerate Progress, an experience of gastric cancer","volume":"13","author":"Waldum","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0135","doi-asserted-by":"crossref","first-page":"C982","DOI":"10.1152\/ajpcell.00498.2009","article-title":"L-Proline induces differentiation of ES cells: a novel role for an amino acid in the regulation of pluripotent cells in culture","volume":"298","author":"Washington","year":"2010","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.571536","article-title":"Gastric stem cells: physiological and pathological perspectives","volume":"8","author":"Xiao","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110320","article-title":"Proline synthesis through PYCR1 is required to support cancer cell proliferation and survival in oxygen-limiting conditions","volume":"38","author":"Westbrook","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0150","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s10120-018-0847-5","article-title":"The clinical implications of FDG-PET\/CT differ according to histology in advanced gastric cancer","volume":"22","author":"Chon","year":"2019","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110048","article-title":"(18)F-fluorodeoxyglucose uptake in advanced gastric cancer correlates with histopathological subtypes and volume of tumor stroma","volume":"145","author":"Seko-Nitta","year":"2021","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0160","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-007-9732-3","article-title":"Central carbon metabolism in the progression of mammary carcinoma","volume":"110","author":"Richardson","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0165","doi-asserted-by":"crossref","first-page":"15267","DOI":"10.1038\/ncomms15267","article-title":"Proline metabolism supports metastasis formation and could be inhibited to selectively target metastasizing cancer cells","volume":"8","author":"Elia","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0170","first-page":"65","article-title":"Comparison of seven cell lines derived from human gastric carcinomas","volume":"36","author":"Motoyama","year":"1986","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0175","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0180","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41420-021-00803-7","article-title":"Establishment of gastric signet ring cell carcinoma organoid for the therapeutic drug testing","volume":"8","author":"Li","year":"2022","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0185","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1016\/j.celrep.2018.02.084","article-title":"Oncogenic IDH1 mutations promote enhanced proline synthesis through PYCR1 to support the maintenance of mitochondrial redox homeostasis","volume":"22","author":"Hollinshead","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0190","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/j.gastro.2020.09.058","article-title":"Epigenetic alterations in the gastrointestinal tract: current and emerging use for biomarkers of cancer","volume":"160","author":"Grady","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0195","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0200","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/jhg.2013.66","article-title":"Histone modifications for human epigenome analysis","volume":"58","author":"Kimura","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0205","first-page":"7","article-title":"Establishment and characterization of a SV40 transformed human fetal gastric epithelial cell line-GES-1","volume":"16","author":"Ke","year":"1994","journal-title":"Zhonghua zhong liu za zhi"},{"key":"10.1016\/j.bbagrm.2022.194829_bb0210","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1128\/MCB.16.7.3454","article-title":"Association of p300 and CBP with simian virus 40 large T antigen","volume":"16","author":"Eckner","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0215","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1128\/JVI.02658-13","article-title":"Two independent regions of simian virus 40 T antigen increase CBP\/p300 levels, alter patterns of cellular histone acetylation, and immortalize primary cells","volume":"87","author":"S\u00e1enz Robles","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0220","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1158\/0008-5472.CAN-20-1323","article-title":"Targeting p300\/CBP attenuates hepatocellular carcinoma progression through epigenetic regulation of metabolism","volume":"81","author":"Cai","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0225","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-20-0751","article-title":"Targeting the p300\/CBP Axis in lethal prostate cancer","volume":"11","author":"Welti","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bbagrm.2022.194829_bb0230","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.molcel.2018.04.011","article-title":"p300-mediated lysine 2-hydroxyisobutyrylation regulates glycolysis","volume":"70","author":"Huang","year":"2018","journal-title":"Mol. Cell"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187493992200044X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187493992200044X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:31:03Z","timestamp":1761744663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187493992200044X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S187493992200044X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagrm.2022.194829","relation":{},"ISSN":["1874-9399"],"issn-type":[{"value":"1874-9399","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epigenetic modification facilitates proline synthase PYCR1 aberrant expression in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagrm.2022.194829","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"194829"}}